M&A Deal Summary

Allergan Acquires Motus Therapeutics

On October 22, 2014, Allergan acquired life science company Motus Therapeutics from Rhythm Pharmaceuticals for 40M USD

Acquisition Highlights
  • This is Allergan’s 11th transaction in the Life Science sector.
  • This is Allergan’s 25th largest (disclosed) transaction.
  • This is Allergan’s 11th transaction in the United States.
Investment Fate
  • Motus Therapeutics was divested to a consortium of strategic buyers in 2016.

M&A Deal Summary
Date 2014-10-22
Target Motus Therapeutics
Sector Life Science
Buyer(s) Allergan
Sellers(s) Rhythm Pharmaceuticals
Deal Type Divestiture
Deal Value 40M USD

Target

Motus Therapeutics

Boston, United States
Motus Therapeutics, Inc. is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases.

Search 202,458 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Parsippany, New Jersey, United States
Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 18 of 38
Sector (Life Science) 11 of 23
Type (Divestiture) 5 of 7
Country (United States) 11 of 27
Year (2014) 5 of 5
Size (of disclosed) 25 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-06 Durata Therapeutics

Chicago, Illinois, United States

Durata Therapeutics, Inc. is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.

Buy $675M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-01-26 Auden Mckenzie Holdings

Ruislip, United Kingdom

Auden Mckenzie Holdings Ltd is a privately owned, dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the U.K.

Buy £306M

Seller(S) 1

SELLER

Rhythm Pharmaceuticals

Boston, Massachusetts, United States
Category Company
Founded 2008
Sector Medical Products
DESCRIPTION

Rhythm is a biopharmaceutical company developing peptide therapeutics that address unmet needs in gastrointestinal diseases and obesity, including obesity caused by genetic deficiencies in the MC4 pathway.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2014) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-27 Motus Therapeutics

Boston, United States

Motus Therapeutics, Inc. is a biopharmaceutical company developing peptide therapeutics for the treatment of gastrointestinal (GI) diseases.

Buy -
Mergr

Product

Company

Legal